Judicious DICER1 testing and surveillance imaging facilitates early diagnosis and cure of pleuropulmonary blastoma
Kris Ann P Schultz, Anne Harris, Gretchen M Williams, Shari Baldinger, Leslie Doros, Patricia Valusek, A Lindsay Frazier, Louis P Dehner, Yoav Messinger, D Ashley Hill, Kris Ann P Schultz, Anne Harris, Gretchen M Williams, Shari Baldinger, Leslie Doros, Patricia Valusek, A Lindsay Frazier, Louis P Dehner, Yoav Messinger, D Ashley Hill
Abstract
Pleuropulmonary blastoma (PPB) and Sertoli-Leydig cell tumor (SLCT) are both associated with germline mutations in DICER1. In this brief report, a maternal history of SLCT led to identification of a deleterious DICER1 mutation in the patient and her asymptomatic infant. Radiographic screening revealed a large Type I PPB, which was completely resected. Identification of DICER1 mutation carriers and imaging of children at risk for PPB may allow detection of PPB in its earliest and most curable form, leading to increased likelihood of surgical cure and decreased risks of treatment-related late effects.
Keywords: DICER1; Sertoli-Leydig cell tumor; genetic testing; lung cysts; pleuropulmonary blastoma.
Conflict of interest statement
Conflicts of Interest: The authors each state that he/she has no conflicts of interest to disclose.
© 2014 Wiley Periodicals, Inc.
Figures
Source: PubMed